Skip to content

Drug interactions

Aprepitant + Etoposide

Severity: Minor

Aprepitant and Etoposide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etoposide is partly metabolized by CYP3A4, so aprepitant may modestly raise its exposure. Studies have not shown a major clinical change, but toxicity such as myelosuppression could theoretically increase.

What this interaction means in plain words

Aprepitant and Etoposide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Aprepitant belongs to Gastrointestinal Tract; Etoposide belongs to Oncology.

Evidence level: Low

Why it happens

Aprepitant inhibits CYP3A4 and may reduce etoposide clearance.

What to do

Monitor blood counts as routine in chemotherapy and no dose adjustment is usually required.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Etoposide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Etoposide?

MediHelp rates the interaction as minor. Aprepitant and Etoposide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Etoposide is partly metabolized by CYP3A4, so aprepitant may modestly raise its exposure. Studies have not shown a major clinical change, but toxicity such as myelosuppression could theoretically increase.

How serious is the interaction between Aprepitant and Etoposide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts as routine in chemotherapy and no dose adjustment is usually required.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in